Literature DB >> 4656512

Fatty acid oxidation by skeletal muscle mitochondria in Duchenne muscular dystrophy.

C H Lin, A J Hudson, K P Strickland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4656512     DOI: 10.1016/0024-3205(72)90075-6

Source DB:  PubMed          Journal:  Life Sci II        ISSN: 0300-9637


× No keyword cloud information.
  4 in total

Review 1.  Hypotheses and recent findings concerning aetiology and pathogenesis of the muscular dystrophies.

Authors:  F Jerusalem
Journal:  J Neurol       Date:  1976       Impact factor: 4.849

2.  Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD).

Authors:  Bharat Lagu; Arthur F Kluge; Effie Tozzo; Ross Fredenburg; Eric L Bell; Matthew M Goddeeris; Peter Dwyer; Andrew Basinski; Ramesh S Senaiar; Mahaboobi Jaleel; Nirbhay Kumar Tiwari; Sunil K Panigrahi; Narasimha Rao Krishnamurthy; Taisuke Takahashi; Michael A Patane
Journal:  ACS Med Chem Lett       Date:  2018-07-31       Impact factor: 4.345

3.  Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.

Authors:  Cara A Timpani; Craig A Goodman; Christos G Stathis; Jason D White; Kamel Mamchaoui; Gillian Butler-Browne; Nuri Gueven; Alan Hayes; Emma Rybalka
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

Review 4.  Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy.

Authors:  Emma Rybalka; Cara A Timpani; Christos G Stathis; Alan Hayes; Matthew B Cooke
Journal:  Nutrients       Date:  2015-11-26       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.